Zusammenfassung
Trotz der Erfolge der antiretroviralen Kombinationstherapie bleibt die HIV-Infektion eine unheilbare Erkrankung. Die Entwicklung von Resistenz wie auch die Toxizität sind die wichtigsten Limitationen der antiretroviralen Kombinationstherapie.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bahner I, Kearns K, Hao QL, Smogorzewska EM, Kohn DB (1996) Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J Virol 70: 4352–4360
Baltimore D. Gene therapy Intracellular immunization (1988) Nature 335: 395–396
Escaich S, Kalfoglou C, Plavec I, Kaushal S, Mosca JD, Bohnlein E (1995) RevM10-mediated inhibition of HIV-1 replication in chronically infected T cells. Hum Gene Ther 6: 625–634
Marasco WA, Haseltine WA, Chen SY (1993) Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. Proc Natl Acad Sci USA 90: 7889–7893
Ojwang JO, Hampel A, Looney DJ, Wong-Staal F, Rappaport J (1992) Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc Natl Acad Sci USA 89: 10802–10806
Pear WS, Nolan GP, Scott ML, Baltimore D (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90: 8392–8396
Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271: 1582–1586
Rossi JJ. Ribozymes (1992) Curr Opin Biotechnol 3: 3–7
Sarver N, Cantin EM, Chang PS et al. (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247: 1222–1225
Schmid I, Uittenbogaart CH, Keld B, Giorgi JV (1994) A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J Immunol Methods 170: 145–157
Sczakiel G, Pawlita M (1991) Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol 65: 468–472
Sullenger BA, Gallardo HF, Ungers GE, Gilboa E (1990) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601–608
Wong-Staal F, Poeschla EM, Looney DJ (1998) A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA. Hum Gene Ther 9: 2407–2425
Yamada O, Kraus G, Leavitt MC, Yu M, Wong-Staal F (1994) Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells. Virology 205: 121–126
Zhou C, Bahner IC, Larson GP, Zaia JA, Rossi JJ, Kohn EB (1994) Inhibition of HIV-1 in human T- lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149: 33–39
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Klebra, C., Pape, M., Grez, M., Hoelzer, D., Klein, S.A. (2000). Anti-HIV Ribozyme verschaffen CD4+ T-Zellen in vitro einen Selektionsvorteil. In: Brockmeyer, N.H., Hoffmann, K., Reimann, G., Stücker, M., Altmeyer, P., Brodt, R. (eds) HIV-Infekt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59683-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-59683-4_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64082-7
Online ISBN: 978-3-642-59683-4
eBook Packages: Springer Book Archive